Skip to main content

Elevance Health Inc Value Stock - Dividend - Research Selection

Anthem

ISIN: US0367521038 , WKN: A12FMV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

2025-04-01
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Impax U.S. Sustainable Economy Fund Q4 2024 Commentary

2025-04-01
During the fourth quarter of 2024, the US International Sustainable Economy portfolio underperformed the Russell 1000 benchmark. Read more here.

Impax Ellevate Global Women's Leadership Fund Q4 2024 Commentary

2025-04-01
In the fourth quarter, the Impax Ellevate Global Women’s Leadership Fund outperformed the MSCI World Index (World Index). Read more here.

Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025

2025-03-31
INDIANAPOLIS, March 31, 2025--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Here’s Why Elevance Health (ELV) Declined in Q4

2025-03-31
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Hotchkis & Wiley Large Cap Fundamental Value Fund returned – 0.91% in the fourth quarter, outperforming the Russell 1000 Value Index’s -1.98% return. […]

Hartford Quality Value ETF Q4 2024 Commentary

2025-03-31
Hartford Quality Value ETF underperformed the Russell 1000 Value Index during the quarter. Read more here.

Insiders At Elevance Health Sold US$12m In Stock, Alluding To Potential Weakness

2025-03-30
Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which may...

abrdn Healthcare Opportunities Fund Q4 2024 Commentary

2025-03-30
The equity portion of the Abrdn Healthcare Opportunities Fund fell (gross) but outperformed its custom benchmark over the quarter. Click here to read the full commentary.

What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space?

2025-03-28
River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, AMG River Road Large Cap Value Select Fund returned 0.43% compared to (1.98%) return for the Russell 1000® Value Index. For […]

ClearBridge Large Cap Value ESG Portfolios Q4 2024 Commentary

2025-03-28
Our quality bias in materials and utilities stood out the most in a quarter that saw a reversal of some of 2024’s themes. Read more here.